ImportRefusal LogoImportRefusal

IND Diagnostic Inc.

⚠️ Moderate Risk

FEI: 3003148151 • Delta, British Columbia • CANADA

FEI

FEI Number

3003148151

📍

Location

Delta, British Columbia

🇨🇦

Country

CANADA
🏢

Address

1629 Foster's Way, , Delta, British Columbia, Canada

Moderate Risk

FDA Import Risk Assessment

41.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

33
Total Refusals
10
Unique Violations
5/30/2012
Latest Refusal
8/13/2002
Earliest Refusal

Score Breakdown

Violation Severity
51.4×40%
Refusal Volume
56.7×30%
Recency
0.0×20%
Frequency
33.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

11814×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

1614×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

3339×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

5088×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

3416×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

3355×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

3364×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

2372×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

20201×

LBLG ADVER

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded because its labeling is misleading in a particular, namely that it fails to reveal facts (non-sterility) that are material with respect to consequences which may result from the use of the article according to the labeling, or advertising, or under such conditions of use as are customary or usual.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

Refusal History

DateProductViolationsDivision
5/30/2012
75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN
341REGISTERED
New Orleans District Office (NOL-DO)
10/13/2010
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
508NO 510(K)
Seattle District Office (SEA-DO)
8/4/2010
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
508NO 510(K)
Minneapolis District Office (MIN-DO)
11/12/2008
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
16DIRECTIONS
2020LBLG ADVER
Seattle District Office (SEA-DO)
6/12/2008
88LDTREAGENT, GENERAL PURPOSE
118NOT LISTED
336INCONSPICU
508NO 510(K)
Cincinnati District Office (CIN-DO)
12/26/2007
81NPRTEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR
118NOT LISTED
Florida District Office (FLA-DO)
5/14/2007
83JXAKIT, SCREENING, URINE
336INCONSPICU
New York District Office (NYK-DO)
7/26/2006
83JTODISCS, STRIPS AND REAGENTS, MICROORGANISM DIFFERENTIATION
16DIRECTIONS
333LACKS FIRM
335LACKS N/C
New Orleans District Office (NOL-DO)
7/26/2006
75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN
16DIRECTIONS
333LACKS FIRM
335LACKS N/C
New Orleans District Office (NOL-DO)
7/26/2006
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
16DIRECTIONS
333LACKS FIRM
335LACKS N/C
New Orleans District Office (NOL-DO)
7/10/2006
67A45PENICILLIN CATEGORY I, TYPE A MEDICATED ARTICLE
118NOT LISTED
72NEW VET DR
New Orleans District Office (NOL-DO)
5/9/2006
83LOMTEST, HEPATITIS B (B ANTIGEN, B SURFACE ANTIGEN, BE ANTIGEN)
118NOT LISTED
237NO PMA
Cincinnati District Office (CIN-DO)
11/22/2005
75CEPRADIOIMMUNOASSAY, LUTEINIZING HORMONE
16DIRECTIONS
333LACKS FIRM
New Orleans District Office (NOL-DO)
11/3/2005
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
16DIRECTIONS
333LACKS FIRM
335LACKS N/C
Seattle District Office (SEA-DO)
9/18/2005
75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN
341REGISTERED
New Orleans District Office (NOL-DO)
9/15/2005
75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN
16DIRECTIONS
333LACKS FIRM
335LACKS N/C
New Orleans District Office (NOL-DO)
9/15/2005
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
16DIRECTIONS
333LACKS FIRM
New Orleans District Office (NOL-DO)
9/6/2005
75CEPRADIOIMMUNOASSAY, LUTEINIZING HORMONE
16DIRECTIONS
Cincinnati District Office (CIN-DO)
9/6/2005
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
16DIRECTIONS
Cincinnati District Office (CIN-DO)
4/8/2005
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
Cincinnati District Office (CIN-DO)
5/6/2004
81MTNTEST, SYPHILIS, TREPONEMAL
118NOT LISTED
16DIRECTIONS
Seattle District Office (SEA-DO)
1/28/2004
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
16DIRECTIONS
508NO 510(K)
Seattle District Office (SEA-DO)
12/3/2003
83JTODISCS, STRIPS AND REAGENTS, MICROORGANISM DIFFERENTIATION
118NOT LISTED
333LACKS FIRM
New Orleans District Office (NOL-DO)
11/19/2003
57YY99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C.
118NOT LISTED
New Orleans District Office (NOL-DO)
10/23/2003
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
508NO 510(K)
New Orleans District Office (NOL-DO)
8/11/2003
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
341REGISTERED
Baltimore District Office (BLT-DO)
7/7/2003
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
508NO 510(K)
New York District Office (NYK-DO)
5/22/2003
75JHJAGGLUTINATION METHOD, HUMAN CHORIONIC GONADOTROPIN
118NOT LISTED
16DIRECTIONS
333LACKS FIRM
Florida District Office (FLA-DO)
5/21/2003
75JJXSINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED)
336INCONSPICU
341REGISTERED
Cincinnati District Office (CIN-DO)
2/6/2003
75JKATUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION
237NO PMA
Florida District Office (FLA-DO)
12/12/2002
88LIYCURVICAL MUCUS PENETRATION TEST
118NOT LISTED
341REGISTERED
508NO 510(K)
Cincinnati District Office (CIN-DO)
12/12/2002
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
341REGISTERED
Cincinnati District Office (CIN-DO)
8/13/2002
88LDTREAGENT, GENERAL PURPOSE
118NOT LISTED
16DIRECTIONS
336INCONSPICU
508NO 510(K)
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is IND Diagnostic Inc.'s FDA import refusal history?

IND Diagnostic Inc. (FEI: 3003148151) has 33 FDA import refusal record(s) in our database, spanning from 8/13/2002 to 5/30/2012.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. IND Diagnostic Inc.'s FEI number is 3003148151.

What types of violations has IND Diagnostic Inc. received?

IND Diagnostic Inc. has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about IND Diagnostic Inc. come from?

All FDA import refusal data for IND Diagnostic Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.